# Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma

> **NCT01719744** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 25 (actual)

## Conditions studied

- Advanced
- Metastatic
- Soft Tissue Sarcoma

## Interventions

- **DRUG:** ENMD-2076

## Key facts

- **NCT ID:** NCT01719744
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01719744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01719744, "Study of ENMD-2076 in Patients With Advanced/Metastatic Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01719744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*